A Study With Imlifidase in Anti-GBM Disease

Clinical trial NCT05679401 · TERMINATED

Trial details

NCT number: NCT05679401
Sponsor: Hansa Biopharma AB
Status: TERMINATED
Phase: Phase 3
Study type: INTERVENTIONAL

Anti-Glomerular Basement Membrane Disease Anti-Glomerular Basement Membrane Antibody Disease Goodpasture Syndrome Good Pasture Syndrome

Start date: 2022-12-22
Primary completion: 2025-06-23
Enrollment: 50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.